@gocastelobranco.bsky.social lab!! We use MPRA & scCRISPRi/a to interrogate possible functions of GWAS-identified Multiple sclerosis risk SNPs in iPSC-derived oligodendrocytes.
www.biorxiv.org/content/10.1...
@gocastelobranco.bsky.social lab!! We use MPRA & scCRISPRi/a to interrogate possible functions of GWAS-identified Multiple sclerosis risk SNPs in iPSC-derived oligodendrocytes.
www.biorxiv.org/content/10.1...
www.nature.com/articles/s41...
www.nature.com/articles/s41...
🧬 No coding needed
📊 Built-in stats tools
🎨 High-quality figures in clicks
💻 Lightweight & deployable
Perfect for bench scientists!
👉 DEMO: guanaco-demo.chen-sysimeta-lab.com
Opening a number of future avenues.
📰 Via
@GenomeWeb
: lnkd.in/djYm_sGg
#epigenetics #singlecell
Opening a number of future avenues.
📰 Via
@GenomeWeb
: lnkd.in/djYm_sGg
#epigenetics #singlecell
ki.varbi.com/what:job/job...
ki.varbi.com/what:job/job...
🕣September 16, 2025. The Royal Swedish Academy of Sciences, Stockholm @scienceacademyswe.bsky.social
Few spots available. Register here: ui.ungpd.com/Events/ed387...
🕣September 16, 2025. The Royal Swedish Academy of Sciences, Stockholm @scienceacademyswe.bsky.social
Few spots available. Register here: ui.ungpd.com/Events/ed387...
After 3 years, Epichrom is revived and will take place in Stockholm on the 12th of June. Great opportunity to share your research and hear about latest epigenetics/chromatin research in Sweden.
Registration is free of charge
www.bartosovic-lab.com/epichrom
After 3 years, Epichrom is revived and will take place in Stockholm on the 12th of June. Great opportunity to share your research and hear about latest epigenetics/chromatin research in Sweden.
Registration is free of charge
www.bartosovic-lab.com/epichrom
@cp-devcell.bsky.social : #Neuroblastoma cells aren’t locked into one single fate—they flip between developmental programs, driving tumor heterogeneity and malignancy. www.sciencedirect.com/science/arti...
@cp-devcell.bsky.social : #Neuroblastoma cells aren’t locked into one single fate—they flip between developmental programs, driving tumor heterogeneity and malignancy. www.sciencedirect.com/science/arti...
Multiple Sclerosis: Past, Present and Future Treatment
June 5th, 2025 | Jacob Berzelius lecture hall @ki.se | Stockholm, Sweden
free registration at:
jirango.com/cview/web/f0...
Multiple Sclerosis: Past, Present and Future Treatment
June 5th, 2025 | Jacob Berzelius lecture hall @ki.se | Stockholm, Sweden
free registration at:
jirango.com/cview/web/f0...
www.nature.com/articles/s41...
www.nature.com/articles/s41...